Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.
about
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transitionDirect regulation of TWIST by HIF-1alpha promotes metastasisState of the science: an update on renal cell carcinomaThe VHL tumor suppressor: master regulator of HIFA natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transitionHypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1Hypoxic control of metastasisHypoxia-inducible factors as molecular targets for liver diseasesInteractions between E-cadherin and microRNA deregulation in head and neck cancers: the potential interplayc-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic CascadeZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistanceA novel microfluidic platform for studying mammalian cell chemotaxis in different oxygen environments under zero-flow conditions.Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasisThe role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapyHypoxia-inducible factor 1 and breast cancer metastasisCommon variation at 2q22.3 (ZEB2) influences the risk of renal cancerDefining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsuPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.Aberrant epigenetic silencing is triggered by a transient reduction in gene expressionInhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agentsZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression.The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1Molecular mechanisms of hypoxia in cancer.Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosisInvolvement of members of the cadherin superfamily in cancerThe role of hypoxia inducible factor-1 in hepatocellular carcinoma.Development of flexible-heteroarotinoids for kidney cancerSynergistic signaling of tumor cell invasiveness by hepatocyte growth factor and hypoxia.Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression.Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K/Akt signalHypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.Targeted genes and interacting proteins of hypoxia inducible factor-1.Multilayer control of the EMT master regulators.Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.HIF-1α confers aggressive malignant traits on human tumor cells independent of its canonical transcriptional functionThe multifaceted von Hippel-Lindau tumour suppressor protein.Redox sensor CtBP mediates hypoxia-induced tumor cell migration.Repression of Zeb1 and hypoxia cause sequential mesenchymal-to-epithelial transition and induction of aid, Oct4, and Dnmt1, leading to immortalization and multipotential reprogramming of fibroblasts in spheres
P2860
Q24301382-500C6502-9833-4059-BC0C-37178C3F87FCQ24316939-3C104760-8CE7-401B-8279-F6AE99644B46Q24630685-700B96F6-19BE-4FCB-812F-657C5C22DB02Q24634592-BB941D73-7C53-4A85-AD4A-5C4C80333510Q24649050-9214C76C-FD7D-4F0C-81CF-9EA77AD5A283Q24681460-F83B69CE-F273-45EA-BE2D-82B77863555DQ26749159-80BFE660-F74B-4F4F-B3BF-53446EDB4E08Q26752304-FCFE42B8-F738-48CA-BDB9-C1235576423CQ26866533-A9BD02F5-59EE-4CDD-BF5A-1C524B777E99Q26998420-981E0265-56C0-42A7-93D8-1BA775DE06CEQ27015111-6FF6EED8-3A52-4A78-BCE2-C9D952E64D1AQ27330270-10625CFC-C930-4297-989F-EDCA0F946289Q28066271-5209E40B-DFF5-430C-885C-400DA6289688Q28067724-462D57F1-AB5C-4A26-885A-F6B0A3C62239Q28087393-F2F0BFA5-E659-4369-92E4-26557FB28112Q28943459-21F694C9-4467-46D0-82BD-102CAEE77F2BQ29615944-08CD2725-ADB4-4E3C-9EAD-B7756E561B36Q30443804-DA3640BA-E875-4AC2-A224-55B740381133Q33417274-ABEC35DF-F27F-4905-96E3-9CC200205618Q33580209-2049216D-4718-4F5E-9B6F-B27729A85EB4Q33671316-DE03B146-A874-49A9-B6CE-26E6421890B8Q33673803-DFC25ACB-C4E0-488D-BD48-780F1E1166D3Q33705108-22BD44AC-375F-486F-AA74-E1B956BBAE5CQ33732623-5EDD6364-F5D7-4E71-859C-E44642636104Q33899441-930BA067-54B5-4E9E-AE0D-8772EDD1CB6EQ33914603-23750837-72FB-4188-ACC8-8905578B72E1Q33926659-7003E36D-EC78-4791-BE5C-840B01974B0AQ33946966-45BF4746-4C56-46B6-8B0A-2FB04FFC2CE9Q34048090-8A067BAA-4EAB-4025-BBED-74F85305B609Q34104712-B075F5E3-8502-425F-964F-ECC9BA5CE6CAQ34170239-0F1D0B84-0B7C-459C-9932-F513ED0B465EQ34186021-597FE6A3-3F75-49A3-A707-E10F78442F30Q34286796-D6C1A6AD-4483-4696-AC54-487AEB7A3005Q34340552-09F6412B-A349-4B40-9EAA-002017A21E03Q34399671-25A166E4-CFDE-4295-9F29-A6EF72DEE14FQ34465977-1C3E50AE-7D42-46A4-863A-79C6241A5BF8Q34586733-C9EDB597-C7EF-4CF4-8DE3-17FA4AB54C4BQ34660062-EAF5EFB8-90D8-4AF3-8F2D-DF8CAA91C60FQ34694766-DB4301B7-1CB1-4481-AC65-2D636450F345Q34698985-498510E4-8A5C-4BE8-989D-7B5211152B20
P2860
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Hypoxia-inducible factor-1-dep ...... d by TCF3, ZFHX1A, and ZFHX1B.
@en
Hypoxia-inducible factor-1-dep ...... d by TCF3, ZFHX1A, and ZFHX1B.
@nl
type
label
Hypoxia-inducible factor-1-dep ...... d by TCF3, ZFHX1A, and ZFHX1B.
@en
Hypoxia-inducible factor-1-dep ...... d by TCF3, ZFHX1A, and ZFHX1B.
@nl
prefLabel
Hypoxia-inducible factor-1-dep ...... d by TCF3, ZFHX1A, and ZFHX1B.
@en
Hypoxia-inducible factor-1-dep ...... d by TCF3, ZFHX1A, and ZFHX1B.
@nl
P2093
P1433
P1476
Hypoxia-inducible factor-1-dep ...... d by TCF3, ZFHX1A, and ZFHX1B.
@en
P2093
Balaji Krishnamachary
David Zagzag
Hideko Nagasawa
Hiroaki Okuyama
Jin H Baek
Karin Rainey
P304
P356
10.1158/0008-5472.CAN-05-3719
P407
P577
2006-03-01T00:00:00Z